CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients
Authors
Keywords
CXCL5, Bladder cancer, Prognosis, Survival, Diagnosis
Journal
TUMOR BIOLOGY
Volume 37, Issue 4, Pages 4569-4577
Publisher
Springer Nature
Online
2015-10-27
DOI
10.1007/s13277-015-4275-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CXCR2/CXCL5 axis contributes to epithelial–mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling
- (2015) Shao-Lai Zhou et al. CANCER LETTERS
- Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer
- (2015) Jong-Baeck Lim et al. CYTOKINE
- CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration
- (2014) Jiajia Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Arsenic Induced Overexpression of Inflammatory Cytokines Based on the Human Urothelial Cell Model in Vitro and Urinary Secretion of Individuals Chronically Exposed to Arsenic
- (2014) Shengnan Liu et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Inflammatory Biomarkers and Bladder Cancer Prognosis: A Systematic Review
- (2014) Alexandra Masson-Lecomte et al. EUROPEAN UROLOGY
- Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
- (2014) G Mowatt et al. HEALTH TECHNOLOGY ASSESSMENT
- CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes
- (2014) Oksana Kowalczuk et al. TUMOR BIOLOGY
- Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer
- (2014) Jianwen Wang et al. WORLD JOURNAL OF UROLOGY
- CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils
- (2013) Shao-Lai Zhou et al. CARCINOGENESIS
- Proteomic signatures of angiogenesis in androgen-independent prostate cancer
- (2013) George S. Karagiannis et al. PROSTATE
- Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis
- (2013) Shunzeng Lv et al. TUMOR BIOLOGY
- Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer
- (2013) Lujia Wang et al. TUMOR BIOLOGY
- USP28 is a potential prognostic marker for bladder cancer
- (2013) Guiying Guo et al. TUMOR BIOLOGY
- Urine markers for detection and surveillance of bladder cancer
- (2013) Evanguelos Xylinas et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- The pros and cons of chemokines in tumor immunology
- (2012) Antonella Viola et al. TRENDS IN IMMUNOLOGY
- Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer
- (2011) Aihua Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
- (2010) Wun-Jae Kim et al. Molecular Cancer
- Inflaming metastasis
- (2009) Alberto Mantovani NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now